Q&A: Understanding the Pharmaceutical Community's Attention on Peptides Drug Topics Save this date: July 23 24, 2026. That is when the FDA Pharmacy Compounding Advisory Committee (PCAC) meets to vote on the legal fate of 7 major peptides. On the table: BPC 157 Selank Research Peptide NuVion The FDA just changed the game for peptides. April 2026 The FDA is reviewing Category 2 peptides for potential removal from restricted status. Full approval for some peptides may be